Quarterly report [Sections 13 or 15(d)]

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 17 $ 1,378,881 $ 8 $ (1,407,550) $ (28,644)
Balance (in shares) at Dec. 31, 2023 17,482,513        
Increase (Decrease) in Stockholders' Equity          
Net income (loss)       (8,247) (8,247)
Net change in unrealized loss on short-term investments     (13)   (13)
Issuance of common stock upon exercise of options   89     89
Issuance of common stock upon exercise of options (in shares) 9,066        
Issuance of common stock upon vesting of RSUs (in shares) 48,658        
Stock-based compensation expense   5,144     5,144
Balance at Mar. 31, 2024 $ 17 1,384,114 (5) (1,415,797) (31,671)
Balance (in shares) at Mar. 31, 2024 17,540,237        
Balance at Dec. 31, 2024 $ 18 1,393,325 10 (1,390,065) 3,288
Balance (in shares) at Dec. 31, 2024 17,710,216        
Increase (Decrease) in Stockholders' Equity          
Net income (loss)       11,446 11,446
Net change in unrealized loss on short-term investments     (12)   (12)
Issuance of common stock upon exercise of options   484     484
Issuance of common stock upon exercise of options (in shares) 30,892        
Issuance of common stock upon vesting of RSUs (in shares) 125,783        
Stock-based compensation expense   3,361     3,361
Balance at Mar. 31, 2025 $ 18 $ 1,397,170 $ (2) $ (1,378,619) $ 18,567
Balance (in shares) at Mar. 31, 2025 17,866,891